Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

T. Baetz; A. Belch; S. Couban; K. Imrie; J. Yau; R. Myers; K. Ding; N. Paul; L. Shepherd; J. Iglesias; R. Meyer; Michael Crump

doi:10.1093/annonc/mdg496

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

T. Baetz, A. Belch, S. Couban, K. Imrie, J. Yau, R. Myers, K. Ding, N. Paul, L. Shepherd, J. Iglesias, R. Meyer, Michael Crump

Research output: Contribution to journal › Article › peer-review

146 Citations (Scopus)

Original language	English
Pages (from-to)	1762-1767
Number of pages	6
Journal	Annals of Oncology
Volume	14
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdg496
Publication status	Published - Dec 2003
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology

Keywords

Gemcitabine
Hodgkin's disease
Salvage chemotherapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdg496

Fingerprint

Dive into the research topics of 'Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group'. Together they form a unique fingerprint.

Cite this

Baetz, T., Belch, A., Couban, S., Imrie, K., Yau, J., Myers, R., Ding, K., Paul, N., Shepherd, L., Iglesias, J., Meyer, R., & Crump, M. (2003). Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group. Annals of Oncology, 14(12), 1762-1767. https://doi.org/10.1093/annonc/mdg496

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group. / Baetz, T.; Belch, A.; Couban, S. et al.
In: Annals of Oncology, Vol. 14, No. 12, 12.2003, p. 1762-1767.

Research output: Contribution to journal › Article › peer-review

Baetz, T, Belch, A, Couban, S, Imrie, K, Yau, J, Myers, R, Ding, K, Paul, N, Shepherd, L, Iglesias, J, Meyer, R & Crump, M 2003, 'Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group', Annals of Oncology, vol. 14, no. 12, pp. 1762-1767. https://doi.org/10.1093/annonc/mdg496

@article{6fd76e355fe14a5fafbccbaa4773cbbd,

title = "Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group",

keywords = "Gemcitabine, Hodgkin's disease, Salvage chemotherapy",

author = "T. Baetz and A. Belch and S. Couban and K. Imrie and J. Yau and R. Myers and K. Ding and N. Paul and L. Shepherd and J. Iglesias and R. Meyer and Michael Crump",

year = "2003",

month = dec,

doi = "10.1093/annonc/mdg496",

language = "English",

volume = "14",

pages = "1762--1767",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease

T2 - A phase II study by the National Cancer Institute of Canada Clinical Trials Group

AU - Baetz, T.

AU - Belch, A.

AU - Couban, S.

AU - Imrie, K.

AU - Yau, J.

AU - Myers, R.

AU - Ding, K.

AU - Paul, N.

AU - Shepherd, L.

AU - Iglesias, J.

AU - Meyer, R.

AU - Crump, Michael

PY - 2003/12

Y1 - 2003/12

KW - Gemcitabine

KW - Hodgkin's disease

KW - Salvage chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=9144246449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144246449&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg496

DO - 10.1093/annonc/mdg496

M3 - Article

C2 - 14630682

AN - SCOPUS:9144246449

SN - 0923-7534

VL - 14

SP - 1762

EP - 1767

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this